AJANTPHARM

Ajanta Pharma Limited

Pharmaceuticals

Share price

₹3,573

Market cap

₹44,693 Cr

1Y return

▲ 50%

A manufacturer of specialty pharmaceutical finished dosages, this company develops and markets formulations across therapeutic categories including ophthalmology, gastroenterology, and dermatology for domestic and international markets. With vertically integrated operations spanning development, manufacturing, and marketing, the company has established a significant presence in India's pharmaceutical sector through its robust distribution network and focus on quality production.

Investors holding Ajanta Pharma Limited

Tata AIA Life Insurance

Institution

1.90%

Recent moves 11

Moves11

Kotak Mutual FundIncreased

Kotak Mutual Fund increased its stake in Ajanta Pharma from 1.59% to 3.28%, buying an additional 21,15,286 shares for approximately ₹723.70 Cr. This includes the acquisition of 21.02 lakh shares at ₹2,968 apiece in a block deal where a promoter entity sold shares worth ₹1,024 crore.

Tata AIA Life InsuranceIncreased

Tata AIA Life Insurance increased its stake in Ajanta Pharma Limited from 1.77% to 1.90%, raising its holding by 165,110 shares.

HDFC Mutual FundNew position

HDFC Mutual Fund entered Ajanta Pharma with 14,19,167 shares, acquiring a 1.14% stake worth ₹48.54 Cr.

Canara Robeco Mutual FundDecreased

Canara Robeco Mutual Fund trimmed its stake in Ajanta Pharma from 1.48% to 1.46%, selling 21,080 shares.

Aditya Birla Sun Life Mutual FundIncreased

Aditya Birla Sun Life Mutual Fund increased its stake in Ajanta Pharma from 1.10% to 2.21%, acquiring an additional 13,84,420 shares for approximately ₹409.98 Cr at an average price of ₹2,968 apiece.

Nippon India Mutual FundDecreased

Nippon India Mutual Fund decreased its stake in Ajanta Pharma from 2.84% to 2.78%, selling 82,630 shares worth ₹28.27 crore.

UTI Mutual FundDecreased

UTI Mutual Fund decreased its stake in Ajanta Pharma from 3.19% to 3.11%, selling 101,727 shares. The value of the sold shares is ₹34.81 crore at a price of ₹3421.40 apiece.

Ravi Agrawal, Trustee Ravi Agrawal TrustDecreased

Ravi Agrawal, Trustee Ravi Agrawal Trust (Promoter) sold 34.5 lakh shares of Ajanta Pharma for ₹1040.93 crore at ₹3017.20 apiece in an open market transaction, decreasing their stake from 13.00% to 10.24%.

Kotak Mutual FundNew position

Kotak Mutual Fund bought 21,02,291 shares of Ajanta Pharma for ₹623.96 Cr at ₹2968.00 apiece in a block deal.

Aditya Birla Sun Life Mutual FundNew position

Aditya Birla Sun Life Mutual Fund bought 13,47,709 shares of Ajanta Pharma Limited for ₹400.00 Cr at ₹2968.00 apiece in a block deal on June 09, 2026. This transaction was part of a larger block deal where a promoter entity sold a 2.8% stake in Ajanta Pharma.

Track the whales in Ajanta Pharma Limited

Get alerted the moment a top investor buys or sells.